---
$id: https://graph.org.ai/products/commodity/51172013
$type: Product
source: UNSPSC
code: "51172013"
title: "Febuprol"
class: "51172000"
classTitle: "Drugs used for gallbladder disease"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Febuprol

**UNSPSC Code**: 51172013
**Class**: [Drugs used for gallbladder disease](Drugs used for gallbladder disease.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholagogue or choleretic agent with the molecular formula C13H20O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B5RKR9Y63Y, chemically known as 2-propanol, 1-n-butoxy-3-phenoxy- but generally known as febuprol, which bears US NIH Compound Identifier 71119. European Medicines Agency schedules Febuprol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07520MIG. The term FEBUPROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). FEBUPROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule febuprol under HS 29094990 and SITC 51617. As of Q4 2014, FEBUPROL remains the US FDA Preferred Term for this commodity. Febuprol bears US NLM identifiers UMLS ID C0060132 and NCI Concept Code C65627. SMILES: O(CC(O)COC1CCCCC1)CCCC.

